ArticleFrontiers in allergy2022

Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab.

Laura J Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.